DermView will roll out its skin imaging services across the UK through the NHS in the new year
Irish chain of hi-tech dermatology clinics DermView will roll out its skin imaging services across the UK through the NHS in the new year.
DermView has just raised €1.9m in a three-times oversubscribed funding round. Seasoned investors include Sean Cotter, Tim Crowley leading a private group from Park Developments, Irrus Investment, Richard Goodbody and Donagh Barry, to name a few.
The business offers hi-tech skin imaging by leading Irish hospital-based consultants which results in quicker diagnosis and treatment plans for patients. It also cuts both public and private waiting lists for dermatological treatment.
The company is now pressing ahead with major expansion plans including opening two new 4,000 sq ft facilities on either side of Dublin, as well as opening in Northern Ireland and across the UK in the new year in partnership with the NHS.
A significant development is its expansion into the UK where DermView has been selected as a chosen partner by the NHS in a consortium to enable skin artificial intelligence (AI) by 2025 across the UK. It was chosen based on the image quality for lesional patients and smart workflows of its platform with the ability to feed data into AI algorithms.
Recent contracts secured by DermView include St James Hospital, Dublin who are using the company’s technology on its entire dermatology waiting list of 3,500 patients for rapid triage and diagnosis, resulting in keeping almost 70% out of the hospital with remote management.
The company is also working with several other major hospitals across the country helping them rapidly reduce waiting lists. Dermatology is the 3rd largest waiting list in the country with waiting lists 3-4 years in most hospitals.
DermView now have their Irish based technology team focusing into ophthalmology under a pilot programme with the Mater Hospital, Dublin and the HSE. Again, with the same aim of rapid triage service directly from the High Street opticians into the hospital.
The company has drawn significant interest from a number of major pharmaceutical companies who are seeking to help the company reach its ambitions and international growth.
Eoin O’Reilly, co-founder and CEO also announced a recently appointed Board of Directors which includes key figures such as former HSE head, Tony O’Brien, and well-known business figures such as Bernard Somers, Tim Crowley, Mike Ryan, Donagh Barry and Consultants Dr. Patrick Ormond & Co-Founder Dr. Rupert Barry.
“I am personally very privileged to have such an extremely experienced board surround me and join the company helping us reach our full ambitions for the business,” O’Reilly said.
Published by Bank of Ireland – ThinkBusiness. You can read the original article here.
